The objective of the assay is to find compounds that inhibit the growth of Giardia lamblia, which is a human pathogen that causes diarrhea outbreaks. The assay focuses on fructose-1,6-bisphosphate aldolase (FBPA), a key enzyme necessary for the survival of G. lamblia. A primary screen is carried out using a 1536-well HTP format, and compounds identified will be further tested for selectivity and evaluated for growth inhibition and cytotoxicity. False positives will be eliminated using a color reaction, and compounds will be selected based on their effectiveness in inhibiting G. lamblia FBPA without interfering with the human form of the enzyme. Is the molecule effective to this assay?